Deferred Income Tax Liabilities, Net of HCW Biologics Inc. from 31 Dec 2022 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.
Summary
HCW Biologics Inc. quarterly Deferred Income Tax Liabilities, Net in USD history and change rate from 31 Dec 2022 to 31 Dec 2024.
  • HCW Biologics Inc. Deferred Income Tax Liabilities, Net for the quarter ending 31 Dec 2024 was $40,909, a 72% decline year-over-year.
Source SEC data
View on sec.gov
Deferred Income Tax Liabilities, Net, Quarterly (USD)
Deferred Income Tax Liabilities, Net, YoY Quarterly Change (%)

HCW Biologics Inc. Quarterly Deferred Income Tax Liabilities, Net (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $40,909 -$106,005 -72% 31 Dec 2024 10-K 28 Mar 2025 2024 FY
Q4 2023 $146,914 +$146,914 31 Dec 2023 10-K 28 Mar 2025 2024 FY
Q4 2022 $0 31 Dec 2022 10-K/A 15 May 2024 2023 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.